Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)

KOSDAQ:036480 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	23,332	27,740	34,542	41,610	39,140	54,530
Market Cap Growth	-20.47%	-19.69%	-16.99%	6.31%	-28.22%	-11.42%
Enterprise Value	33,606	39,613	47,686	54,480	47,642	67,675
Last Close Price	6140.00	7300.00	8998.61	10752.02	10045.31	13893.76

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	66.51	46.37	-	-	22.98	62.97
PS Ratio	0.93	1.07	1.45	1.63	1.54	2.27
PB Ratio	0.68	0.78	0.98	1.11	1.01	1.47
P/TBV Ratio	0.68	0.79	0.99	1.13	1.02	1.49
P/FCF Ratio	37.84	26.31	26.41	-	-	-
P/OCF Ratio	23.94	19.67	16.43	-	33.88	24.75

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	1.33	1.52	2.00	2.13	1.87	2.82
EV/EBITDA Ratio	18.42	12.17	292.26	25.07	20.03	23.54
EV/EBIT Ratio	-	55.46	-	-	-	200.75
EV/FCF Ratio	54.51	37.57	36.47	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.56	0.56	0.58	0.64	0.57	0.60
Debt / EBITDA Ratio	10.37	6.14	125.20	11.05	9.26	7.77
Debt / FCF Ratio	31.14	18.95	15.62	-	-	-
Net Debt / Equity Ratio	0.30	0.30	0.32	0.33	0.24	0.34
Net Debt / EBITDA Ratio	5.55	3.25	69.71	5.65	3.86	4.32
Net Debt / FCF Ratio	16.67	10.04	8.70	-4.93	-7.91	-16.24
Asset Turnover	0.44	0.45	0.39	0.40	0.40	0.38
Inventory Turnover	1.63	1.87	1.73	1.73	1.87	1.86
Quick Ratio	1.74	1.71	2.87	1.54	1.51	2.44
Current Ratio	3.51	2.96	5.22	2.76	2.70	4.46
Return on Equity (ROE)	1.02%	1.70%	-4.88%	-1.78%	4.49%	2.36%
Return on Assets (ROA)	-0.72%	0.77%	-1.58%	-0.66%	-0.32%	0.34%
Return on Invested Capital (ROIC)	-1.48%	1.54%	-3.23%	-1.41%	-0.51%	0.69%
Return on Capital Employed (ROCE)	-1.30%	1.40%	-2.90%	-1.30%	-0.60%	0.60%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	1.50%	2.16%	-5.12%	-1.63%	4.35%	1.59%
FCF Yield	2.64%	3.80%	3.79%	-5.98%	-2.96%	-1.40%
Payout Ratio	81.25%	47.64%	-	-	16.73%	37.30%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error